Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients

Hypertension Research

Volumn 31, Issue 1, 2008, Pages 83-88

  Gohda, Tomohito ^a   Goth, Hiromichi ^a   Tanimoto, Mitsuo ^a   Sato, Michiko ^a   Io, Hiroaki ^a   Kaneko, Kayo ^a   Hamada, Chieko ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Abdominal adipose tissue; C reactive protein; Hemodialysis; Insulin resistance; Obesity

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ABDOMINAL FAT; ABDOMINAL SUBCUTANEOUS FAT; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; MULTIPLE REGRESSION; PATHOGENESIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL;

ABDOMINAL FAT; AGED; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS;

EID: 40149095409     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.83     Document Type: Article

References (26)

1. Saijo Y, Kiyota N, Kawasaki Y, et al: Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 2004; 6: 249-258.
2. Nakanishi N, Shiraishi T, Wada M: Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study. Intern Med 2005; 44: 542-547.
3. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
4. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE: Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005; 294: 326-333.
5. Mohamed-Ali V, Goodrick S, Rawesh A, et al: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
6. Mak RH, DeFronzo RA: Glucose and insulin metabolism in uremia. Nephron 1992; 61: 377-382.
7. Kobayashi S, Maejima S, Ikeda T, Nagase M: Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2000; 15: 65-70.
8. Gautier JF, Mourier A, de Kerviler E, et al: Evaluation of abdominal fat distribution in noninsulin-dependent diabetes mellitus: relationship to insulin resistance. J Clin Endocrinol Metab 1998; 83: 1306-1311.
9. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE: Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 137-144.
10. Shoji T, Emoto M, Nishizawa Y: HOMA index to assess insulin resistance in renal failure patients. Nephron 2001; 89: 348-349.
11. Degoulet P, Legrain M, Reach I, et al: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 1982; 31: 103-110.
12. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK: Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999; 55: 1560-1567.
13. Kopple JD, Zhu X, Lew NL, Lowrie EG: Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999; 56: 1136-1148.
14. Combe C, Chauveau P, Laville M, et al, French Study Group Nutrition in Dialysis: Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis 2001; 37 (1 Suppl 2): S81-S88.
15. Iwasaki T, Nakajima A, Yoneda M, Terauchi Y: Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus. Endocr J 2006; 53: 345-356.
16. Yatagai T, Nagasaka S, Taniguchi A, et al: Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003; 52: 1274-1278.
17. Taniguchi A, Nakai Y, Sakai M, et al: Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 2002; 51: 544-548.
18. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM: Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996; 45: 1684-1693.
19. Kelley DE, Williams KV, Price JC, McKolanis TM, Goodpaster BH, Thaete FL: Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab 2001; 86: 5412-5419.
20. Yamauchi T, Kuno T, Takada H, Nagura Y, Kanmatsuse K, Takahashi S: The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 1842-1847.
21. Odamaki M, Furuya R, Ohkawa S, et al: Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 1999; 14: 2427-2432.
22. Higashi K, Ito T, Nakajima K, et al: Remnant-like particles cholesterol is higher in diabetic patients with coronary artery disease. Metabolism 2001; 50: 1462-1465.
23. Takase H, Shoji K, Hase T, et al: Effect of diacylglycerol on postprandial lipid metabolism in non-diabetic subjects with and without insulin resistance. Atherosclerosis 2005; 180: 197-204.
24. Hirany S, O'Byrne D, Devaraj S, et al: Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease. Clin Chem 2000; 46: 667-672.
25. Inoue T, Inagaki H, Hashimoto S, et al: Remnant-like lipoprotein particle level and insulin resistance are associated with in-stent restenosis in patients with stable angina. Coron Artery Dis 2007; 18: 319-322.
26. Shinohara K, Shoji T, Emoto M, et al: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 1894-1900.